Correlation Between Horizon Pharma and Roche Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Horizon Pharma and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Horizon Pharma and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Horizon Pharma PLC and Roche Holding AG, you can compare the effects of market volatilities on Horizon Pharma and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Horizon Pharma with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Horizon Pharma and Roche Holding.

Diversification Opportunities for Horizon Pharma and Roche Holding

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Horizon and Roche is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Horizon Pharma PLC and Roche Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding AG and Horizon Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Horizon Pharma PLC are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding AG has no effect on the direction of Horizon Pharma i.e., Horizon Pharma and Roche Holding go up and down completely randomly.

Pair Corralation between Horizon Pharma and Roche Holding

Given the investment horizon of 90 days Horizon Pharma PLC is expected to under-perform the Roche Holding. In addition to that, Horizon Pharma is 1.28 times more volatile than Roche Holding AG. It trades about -0.08 of its total potential returns per unit of risk. Roche Holding AG is currently generating about 0.0 per unit of volatility. If you would invest  30,409  in Roche Holding AG on August 29, 2024 and sell it today you would lose (2,108) from holding Roche Holding AG or give up 6.93% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy13.74%
ValuesDaily Returns

Horizon Pharma PLC  vs.  Roche Holding AG

 Performance 
       Timeline  
Horizon Pharma PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Horizon Pharma PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Horizon Pharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Roche Holding AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roche Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Horizon Pharma and Roche Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Horizon Pharma and Roche Holding

The main advantage of trading using opposite Horizon Pharma and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Horizon Pharma position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.
The idea behind Horizon Pharma PLC and Roche Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon